Formulation buffer

OTHER5 trials

Sponsors

International AIDS Vaccine Initiative, Novavax, Scarless Laboratories, Inc., Advagene Biopharma Co. Ltd.

Conditions

Allergic RhinitisEosinophilic AsthmaHIV InfectionsHuman Immunodeficiency Virus InfectionsRespiratory Syncytial Virus InfectionsScars

Phase 1

Safety and Efficacy of SLI-F06 in Wound Healing and Scar Appearance

CompletedNCT03880058

Scarless Laboratories, Inc.Scars

Start: 2019-03-03End: 2021-05-18Updated: 2023-04-18

Tolerability and Potential Efficacy of AD17002 in Subjects With Allergic Rhinitis

CompletedNCT04088721

Advagene Biopharma Co. Ltd.Allergic Rhinitis

Start: 2019-03-26End: 2020-12-11Updated: 2025-09-16

Phase 2

Safety and Immunogenicity Study of tgAAC09, an HIV Vaccine in an Adeno-associated Virus (AAV) Capsid

CompletedNCT00888446

International AIDS Vaccine InitiativeHIV Infections, Human Immunodeficiency Virus Infections

Start: 2005-10-31End: 2007-12-31Updated: 2012-12-17

A Multi-dose Study on the Safety and Efficacy of Self-administered Intranasal AD17002 Treatment for Eosinophilic Asthma

Not yet recruitingNCT07250594

Advagene Biopharma Co. Ltd.Eosinophilic Asthma

Start: 2025-12-31End: 2026-12-31Target: 126Updated: 2025-11-26

Phase 3

A Study to Determine the Safety and Efficacy of the RSV F Vaccine to Protect Infants Via Maternal Immunization

CompletedNCT02624947

NovavaxRespiratory Syncytial Virus Infections

Start: 2015-12-31End: 2019-07-12Updated: 2025-05-06

Related Papers

Respiratory Syncytial Virus Vaccination during Pregnancy and Effects in Infants

New England Journal of Medicine2020-07-29405 citations

Burden of Respiratory Syncytial Virus Infection in South African Human Immunodeficiency Virus (HIV)-Infected and HIV-Uninfected Pregnant and Postpartum Women: A Longitudinal Cohort Study

Clinical Infectious Diseases2017-12-1533 citations